MoneyMe Limited (MME.AX)
AUD 0.17
(-2.86%)
AUD 0.17
(-2.86%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -50.78 Million | 208.38 Million | 68.81 Million | 30.14 Million | 18.23 Million | 12.69 Million |
| Net Income | 22.72 Million | 12.28 Million | -50.36 Million | -7.92 Million | 1.29 Million | 324 Thousand |
| Depreciation & Amortization | 10.94 Million | 11.34 Million | 2.23 Million | 1.68 Million | 985 Thousand | 231 Thousand |
| Deferred income taxes | - | 54.23 Million | 2.58 Million | -2.1 Million | -3.53 Million | -230 Thousand |
| Stock-based compensation | 1.1 Million | 2.12 Million | 2.45 Million | 1.31 Million | 641 Thousand | 28 Thousand |
| Change in working capital | -96.64 Million | 77.52 Million | 6.72 Million | 1.21 Million | 2.87 Million | 492 Thousand |
| Other non-cash items | 11.09 Million | 50.87 Million | 105.18 Million | 35.95 Million | 15.97 Million | 11.51 Million |
| Investing Cash Flow | -4.91 Million | -8.56 Million | -689.08 Million | -224.98 Million | -61.18 Million | -47.3 Million |
| Investments in PPE | -4.91 Million | -8.56 Million | -3.85 Million | -2.55 Million | -2.79 Million | -624 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -14.52 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -4.83 Million | -5.97 Million | -670.7 Million | -222.43 Million | -58.39 Million | -46.68 Million |
| Financing Cash Flow | 37.6 Million | -188.78 Million | 674.77 Million | 185.62 Million | 72.26 Million | 37.17 Million |
| Debt repayment | -42.65 Million | -248.12 Million | -675.58 Million | -186.32 Million | -31.56 Million | -37.17 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -2.08 Million | - | - | - | - |
| Common Stock Issuance | - | 60.45 Million | - | - | 41.31 Million | - |
| Other Financing Activities | -5.04 Million | 190.72 Million | 1.35 Billion | 371.95 Million | 62.51 Million | 36.19 Million |
| Accounts receivables | -102.85 Million | 88.62 Million | -1.87 Million | -35 Thousand | -493 Thousand | -49 Thousand |
| Accounts payables | 821 Thousand | -9.58 Million | 6.73 Million | 2.3 Million | 814 Thousand | 649 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -96.64 Million | -1.51 Million | 1.86 Million | -1.04 Million | 2.55 Million | -108 Thousand |
| Cash at beginning of period | 91.71 Million | 80.67 Million | 26.16 Million | 35.37 Million | 6.06 Million | 3.5 Million |
| Cash at end of period | 73.63 Million | 91.71 Million | 80.67 Million | 26.16 Million | 35.37 Million | 6.06 Million |
| Capital Expenditure | -4.91 Million | -8.56 Million | -3.85 Million | -2.55 Million | -2.79 Million | -624 Thousand |
| Effect of forex changes on cash | - | -16.11 Million | - | - | - | -307.00 |
| Net cash flow / Change in cash | -18.08 Million | 11.03 Million | 54.51 Million | -9.21 Million | 29.31 Million | 2.55 Million |
| Free Cash Flow | -55.69 Million | 199.82 Million | 64.96 Million | 27.59 Million | 15.44 Million | 12.07 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.72 Million | 16.55 Million | 6.17 Million | 12.28 Million | 3.48 Million | 8.79 Million |
| Depreciation & Amortization | 10.94 Million | 5.31 Million | 5.63 Million | 11.34 Million | 5.3 Million | 6.03 Million |
| Deferred income taxes | - | - | - | 54.23 Million | -90.08 Million | - |
| Stock-based compensation | - | 1.1 Million | - | 2.12 Million | 2.12 Million | - |
| Change in working capital | -101.64 Million | -96.64 Million | - | 77.52 Million | 77.34 Million | - |
| Other non-cash items | 141.12 Million | 8.05 Million | 14.31 Million | 50.87 Million | 137.05 Million | 70.38 Million |
| Investing Cash Flow | -4.91 Million | -2.47 Million | -2.43 Million | -8.56 Million | -77.67 Million | 69.1 Million |
| Investments in PPE | -4.91 Million | -55 Thousand | -2.43 Million | -8.56 Million | -2.28 Million | -6.27 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -2.42 Million | -2.41 Million | -5.97 Million | -75.38 Million | 75.38 Million |
| Financing Cash Flow | 37.6 Million | 69.79 Million | -32.18 Million | -188.78 Million | -45.32 Million | -143.45 Million |
| Debt repayment | -38.86 Million | -70.39 Million | -31.52 Million | -248.12 Million | -84.67 Million | -163.45 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -2.08 Million | - | - |
| Common Stock Issuance | - | 34 Thousand | -34 Thousand | 60.45 Million | 39.87 Million | 20.58 Million |
| Other Financing Activities | - | 69.79 Million | -3.78 Million | 190.72 Million | -45.05 Million | 20.3 Million |
| Accounts receivables | -102.85 Million | - | - | 88.62 Million | - | - |
| Accounts payables | 821 Thousand | - | - | -9.58 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 389 Thousand | -96.64 Million | - | -1.51 Million | 77.34 Million | - |
| Cash at beginning of period | 91.71 Million | 71.94 Million | 91.71 Million | 80.67 Million | 79.47 Million | 80.67 Million |
| Cash at end of period | 73.63 Million | 73.63 Million | 71.94 Million | 91.71 Million | 91.71 Million | 79.47 Million |
| Capital Expenditure | -4.91 Million | -55 Thousand | -2.43 Million | -8.56 Million | -2.28 Million | -6.27 Million |
| Effect of forex changes on cash | - | - | -1.00 | -16.11 Million | -91.71 Million | 80.67 Million |
| Net cash flow / Change in cash | -18.08 Million | 1.68 Million | -19.77 Million | 11.03 Million | 12.23 Million | -1.19 Million |
| Free Cash Flow | -55.69 Million | -65.68 Million | 12.41 Million | 199.82 Million | 132.94 Million | 66.87 Million |
WOCKPHARMA
603390
0L8B
RSMXF
QYBX
FSC